Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date | No Grouping
Number of items: 73.

Journal Article

Adler, J., Schmidt, M., Adler, C., Cremer, B., Rudolph, V. and Rosenkranz, S. (2020). Progressive Dyspnea due to neuroendocrine Tumor. Kardiologe, 14 (4). S. 294 - 298. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1864-9726

Angermann, C. E. and Rosenkranz, S. (2018). Telemonitoring and pulmonary artery pressure-guided treatment of heart failure. Internist, 59 (10). S. 1041 - 1054. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1432-1289

Barbera, J., Humbert, M., Grueig, E., Jansa, P., Rosenkranz, S., Gall, H., Simonneau, G., Klotsche, J., Chang, M. and Hoeper, M. (2020). Safety of Riociguat for the Treatment of Pulmonary Arterial Hypertension Associated with Connective Tissue Disease: Data from the EXPERT Registry. Am. J. Respir. Crit. Care Med., 201. NEW YORK: AMER THORACIC SOC. ISSN 1535-4970

Batool, M., Berghausen, E. M., Vantler, M., Zierden, M., Baldus, S., Rosenkranz, S. and Ten Freyhaus, H. (2018). Deficiency of the six-transmembrane protein Stamp2 promotes hypoxia-induced pulmonary vascular remodeling and pulmonary hypertension via cross-talk between macrophages and smooth muscle cells. Eur. Heart J., 39. S. 238 - 239. OXFORD: OXFORD UNIV PRESS. ISSN 1522-9645

Belz, D., Ahrazoglu, M., Moinzadeh, P., Rosenkranz, S. and Hunzelmann, N. (2017). Anaemia and Iron Deficiency in patients with systemic sclerosis. J. Dtsch. Dermatol. Ges., 15. S. 89 - 90. HOBOKEN: WILEY. ISSN 1610-0387

Berghausen, E., Skoruppa, C., Vantler, M., Behringer, A., Joseph, C., Baldus, S. and Rosenkranz, S. (2016). PI3Kdelta mediates growth factor induced PASMC proliferation and hypoxia induced pulmonary hypertension via non-catalytic mechanisms. Eur. Heart J., 37. S. 106 - 108. OXFORD: OXFORD UNIV PRESS. ISSN 1522-9645

Berghausen, E. M., Behringer, A., Vantler, M., Baldus, S. and Rosenkranz, S. (2016). The Orally Available P110a Selective Pi3k Inhibitor Byl719 Reduces Hypoxia-Induced Ph In Mice. Am. J. Respir. Crit. Care Med., 193. NEW YORK: AMER THORACIC SOC. ISSN 1535-4970

Berghausen, E. M., Feik, L., Zierden, M., Vantler, M. and Rosenkranz, S. (2019). Key inflammatory pathways underlying vascular remodeling in pulmonary hypertension. Herz, 44 (2). S. 130 - 138. MUNICH: URBAN & VOGEL. ISSN 1615-6692

Berghausen, E. M., Janssen, W., Vantler, M., Ten Freyhaus, H., Baldus, S., Schermuly, R. and Rosenkranz, S. (2014). Pharmacological Inhibition Of The Pi 3-Kinase Isoform P110 alpha Prevents Vascular Remodeling And Experimental Ph. Am. J. Respir. Crit. Care Med., 189. NEW YORK: AMER THORACIC SOC. ISSN 1535-4970

Berman-Rosenzweig, E., Allen, R., Rosenkranz, S., Busse, D., Platt, D. and Ghofrani, H. -A. (2016). Application Of The Criteria For Satisfactory Clinical Response To Riociguat Treatment Of Patients With Pulmonary Arterial Hypertension (patent-1 And Patent-2). Am. J. Respir. Crit. Care Med., 193. NEW YORK: AMER THORACIC SOC. ISSN 1535-4970

Bokredenghel, S., Mollenhauer, M., Bablok, S., Ruther, T., Proksch, C., Berghausen, E. M., Vantler, M., Rosenkranz, S., Baldus, S., Rudolph, V. and Ten Freyhaus, H. (2018). Stamp2 diminishes structural remodeling and systolic dysfunction in post-ischemic hearts by its anti-inflammatory properties. Eur. Heart J., 39. S. 186 - 187. OXFORD: OXFORD UNIV PRESS. ISSN 1522-9645

Delcroix, M., Staehler, G., Ghofrani, H. A., Gruenig, E., Held, M., Halank, M., Klose, H., Noordegraaf, A. Vonk, Rosenkranz, S., Huscher, D., Pittrow, D. and Hoeper, M. (2018). 2015 ERS/ESC Pulmonary Arterial Hypertension Risk Assessment Model Is also Applicable for Patients with Chronic Thromboembolic Pulmonary Hypertension. Am. J. Respir. Crit. Care Med., 197. NEW YORK: AMER THORACIC SOC. ISSN 1535-4970

Dumitrescu, D., Gerhardt, F., Viethen, T., Erdmann, E. and Rosenkranz, S. (2011). 70-year-old woman with cardiac hypertrophy and severe pulmonary hypertension: pre- or postcapillary? Dtsch. Med. Wochenschr., 136 (50). S. 2594 - 2599. STUTTGART: GEORG THIEME VERLAG KG. ISSN 1439-4413

Dumitrescu, D., Kovacs, G., Nagel, C., Winkler, J., Halank, M., Gruenig, E., Olschewski, H., Ewert, R. and Rosenkranz, S. (2014). Influence of pulmonary arterial occlusion pressure on the diagnostic accuracy of end-tidal pCO2 measurement during exercise for the detection of scleroderma-associated pulmonary arterial hypertension. Eur. Heart J., 35. S. 73 - 74. OXFORD: OXFORD UNIV PRESS. ISSN 1522-9645

Dumitrescu, D., Kramer, T., Gerhardt, F., Natsina, K., Viethen, T., Baldus, S. and Rosenkranz, S. (2017). Improvement of pulmonary diffusion capacity after intravenous iron substitution in patients with iron deficiency and pulmonary hypertension. Eur. Heart J., 38. S. 748 - 749. OXFORD: OXFORD UNIV PRESS. ISSN 1522-9645

Dumitrescu, D., Kramer, T., Hagmanns, H., Gerhardt, F., Viethen, T., Baldus, S. and Rosenkranz, S. (2018). Intravenous Iron Substitution Improves Pulmonary Diffusion Capacity in Patients with Iron Deficiency and Pulmonary Hypertension. Am. J. Respir. Crit. Care Med., 197. NEW YORK: AMER THORACIC SOC. ISSN 1535-4970

Dumitrescu, D., Kramer, T., Hagmanns, H., Gerhardt, F., Viethen, T., Baldus, S. and Rosenkranz, S. (2018). Intravenous iron substitution improves pulmonary diffusion capacity in patients with iron deficiency and precapillary pulmonary hypertension. Eur. Heart J., 39. S. 318 - 320. OXFORD: OXFORD UNIV PRESS. ISSN 1522-9645

Dumitrescu, D., Nagel, C., Kovacs, G., Bollmann, T., Halank, M., Winkler, J., Hellmich, M., Grunig, E., Olschewski, H., Ewert, R. and Rosenkranz, S. (2016). Peak oxygen uptake during exercise is able to exclude scleroderma-associated pulmonary arterial hypertension with a high probability. Eur. Heart J., 37. S. 1186 - 1187. OXFORD: OXFORD UNIV PRESS. ISSN 1522-9645

Dumitrescu, D., Viethen, T., Gerhardt, F., Moinzadeh, P., Hunzelmann, N., Baldus, S. and Rosenkranz, S. (2014). Carbon dioxide output kinetics during early recovery from exercise are specifically altered in scleroderma patients with pulmonary arterial hypertension. Eur. Heart J., 35. S. 76 - 77. OXFORD: OXFORD UNIV PRESS. ISSN 1522-9645

Dumitrescu, D., Viethen, T., Gerhardt, F., Moinzadeh, P., Hunzelmann, N. and Rosenkranz, S. (2014). Carbon Dioxide Output Kinetics During Early Recovery From Exercise Are Specifically Altered In Scleroderma Patients With Pulmonary Arterial Hypertension In Different Stages. Am. J. Respir. Crit. Care Med., 189. NEW YORK: AMER THORACIC SOC. ISSN 1535-4970

Egenlauf, B., Nagel, C., Ewert, R., Lehmkuhl, H., Rosenkranz, S., Benjamin, N., Schwenger, V., Herth, F. and Gruenig, E. (2018). Safety and efficacy of immunoadsorption as an add-on to medical treatment in patients with severe idiopathic pulmonary arterial hypertension (IPAH). Eur. Heart J., 39. S. 320 - 321. OXFORD: OXFORD UNIV PRESS. ISSN 1522-9645

Eichstaedt, C., Sassmannshausen, Z., Gall, H., Seyfarth, H. J., Lerche, M., Halank, M., Xanthouli, P., Harutyunova, S., Egenlauf, B., Milger, K., Rosenkranz, S., Ewert, R., Lankeit, M., Lange, T., Hinderhofer, K. and Gruenig, E. (2020). Genetic findings in patients with different forms of pulmonary hypertension. Pneumologie, 74. S. S22 - 1. STUTTGART: GEORG THIEME VERLAG KG. ISSN 1438-8790

Ghofrani, H. A., Distler, O., Gerhardt, F., Gorenflo, M., Gruenig, E., Haefell, W. E., Held, M., Hoeper, M. M., Kaehler, C.-M., Kaemmerer, H., Klose, H., Koellner, V., Kopp, B., Mebus, S., Meyer, A., Miera, O., Pittrow, D., Riemekasten, G., Rosenkranz, S., Schranz, D., Voswinckel, R. and Olschewski, H. (2010). Treatment of pulmonary arterial hypertension (PAH): Recommendations of the Cologne Consensus Conference 2010. Dtsch. Med. Wochenschr., 135. S. S87 - 15. STUTTGART: GEORG THIEME VERLAG KG. ISSN 1439-4413

Held, M. and Rosenkranz, S. (2015). Pulmonary hypertension with lung and left-sided heart diseases. Pneumologe, 12 (5). S. 410 - 417. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1613-6055

Herkenrath, S. D., Treml, M., Kietzmann, I, Anduleit, N., Sofianos, G., Matthes, S., Hagmeyer, L., Rosenkranz, S. and Randerath, W. J. (2020). A pulmonary artery Wedge Pressure of 21 mmHg under Stress separates pre- and postcapillary pulmonary Hypertension under Stress. Pneumologie, 74. S. S125 - 1. STUTTGART: GEORG THIEME VERLAG KG. ISSN 1438-8790

Hoeper, M. M., Apitz, C., Gruenig, E., Halank, M., Ewert, R., Kaemmerer, H., Kabitz, H. -J., Kaehler, C., Klose, H., Leuchte, H., Ulrich, S., Olsson, K. M., Distler, O., Rosenkranz, S. and Ghofrani, H. A. (2016). Targeted therapy of pulmonary arterial hypertension: Recommendations of the Cologne Consensus Conference 2016. Dtsch. Med. Wochenschr., 141. S. S33 - 11. STUTTGART: GEORG THIEME VERLAG KG. ISSN 1439-4413

Hoeper, M. M., Ghofrani, H. -A., Benza, R. L., Corris, P. A., Gibbs, S., Klinger, J. R., Langleben, D., McLaughlin, V. V., Peacock, A., Rosenkranz, S., Vonk-Noordegraaf, A., White, J., Kleinjung, F., Meier, C. and Simonneau, G. (2017). Rationale And Design Of The Replace Trial: Riociguat Replacing Phosphodiesterase 5 Inhibitor (pde5i) Therapy Evaluated Against Continued Pde5i Therapy In Patients With Pulmonary Arterial Hypertension (pah). Am. J. Respir. Crit. Care Med., 195. NEW YORK: AMER THORACIC SOC. ISSN 1535-4970

Hoeper, M. M., Opitz, C., Olschewski, H., Ulrich, S., Speich, R., Behr, J., Halank, M., Wilkens, H., Klose, H., Lange, T. J., Gruenig, E., Seeger, W., Ewert, R., Borst, M. M., Welte, T., Rosenkranz, S. and Ghofrani, H. Ardeschir (2014). Use of Imatinib in Patients with Pulmonary Arterial Hypertension Joint Statement of the Group Pulmonary Hypertension of the German Society for Pneumology and the Working Group Pulmonary Hypertension (AG25) of the German Society of Cardiology (DGK). Dtsch. Med. Wochenschr., 139. S. S151 - 4. STUTTGART: GEORG THIEME VERLAG KG. ISSN 1439-4413

Joseph, C., Berghausen, E. M., Vantler, M., Baldus, S. and Rosenkranz, S. (2016). Deficiency of protease-activated receptor 1 and 2 reduce the progression of experimental pulmonary hypertension in mice. Eur. Heart J., 37. S. 832 - 834. OXFORD: OXFORD UNIV PRESS. ISSN 1522-9645

Klose, H., Gall, H., Ghofrani, H., Gruenig, E., Humbert, M., Simonneau, G., Halank, M., Langleben, D., Snijder, R. J., Escribano, P., Mielniczuk, L. M., Lange, T., Vachiery, J., Wirtz, H., Helmersen, D. S., Tsangaris, I., Barbera, J. A., Pepke-Zaba, J., Boonstra, A., Rosenkranz, S., Ulrich, S., Mascherbauer, R., Delcroix, M., Jansa, P., Gomez Sanchez, M. A., Klotsche, J., Meier, C., Pittrow, D. and Hoeper, M. M. (2018). Riociguat for the Treatment of Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension: Safety Update from the EXPERT Registry. Am. J. Respir. Crit. Care Med., 197. NEW YORK: AMER THORACIC SOC. ISSN 1535-4970

Klose, H., Opitz, C., Bremer, H., Ewert, R., Bonderman, D., Rosenkranz, S., Seeger, W., Schmeisser, A., Harbaum, L., Buerke, M., Ghofrani, H. Ardeschir, Borst, M. M., Leuchte, H. H., Lange, T. J., Behr, J., Ulrich, S., Lang, I., Olschewski, H., Gall, H., Kabitz, H. -J., Kleber, F. -X., Held, M., Hoeper, M. M. and Gruenig, E. (2014). Targeted Therapy of pulmonary arterial Hypertension (PAH). Dtsch. Med. Wochenschr., 139. S. S142 - 9. STUTTGART: GEORG THIEME VERLAG KG. ISSN 1439-4413

Kramer, T., Orlova, K., Gerhardt, F., Dumitrescu, D., Ten Freyhaus, H., Baldus, S. and Rosenkranz, S. (2017). Therapeutic effects of phosphodiesterase 5 inhibitors in patients with heart failure with preserved ejection fraction (HFpEF) and combined post-and pre-capillary pulmonary hypertension (Cpc-PH). Eur. Heart J., 38. S. 545 - 547. OXFORD: OXFORD UNIV PRESS. ISSN 1522-9645

Kramer, T., Orlova, K., Gerhardt, F., Dumitrescu, D., Ten Freyhaus, H., Baldus, S. and Rosenkranz, S. (2017). Therapeutic potential of phosphodiesterase 5 inhibitors in patients with heart failure with preserved ejection fraction (HFpEF) and combined post- and pre-capillary pulmonary hypertension (Cpc-PH). Eur. J. Heart Fail., 19. S. 531 - 532. HOBOKEN: WILEY. ISSN 1879-0844

Lang, I., McLaughlin, V., Barbera, J. A., Gomez-Sanchez, M. A., Hoeper, M. M., Jansa, P., Speich, R., Rosenkranz, S., Meier, C., Mueller, K., Nikkho, S., D'Armini, A. M. and Pepke-Zaba, J. (2015). Early Access Study (eas) Of Riociguat In Patients With Chronic Thromboembolic Pulmonary Hypertension (cteph): Baseline Characteristics And Comparison With Registry Data. Am. J. Respir. Crit. Care Med., 191. NEW YORK: AMER THORACIC SOC. ISSN 1535-4970

Leuchte, H. H., Behr, J., Ewert, R., Ghofrani, H. A., Gruenig, E., Halank, M., Held, M., Klose, H., Rosenkranz, S., Schermuly, R. T., Wilkens, H. and Hoeper, M. M. (2015). Riociguat: Stimulator of Soluble Guanylate-cyclase. Pneumologie, 69 (3). S. 135 - 144. STUTTGART: GEORG THIEME VERLAG KG. ISSN 1438-8790

Leuchte, H. H., Behr, J., Ewert, R., Ghofrani, H. A., Gruenig, E., Halank, M., Held, M., Klose, H., Rosenkranz, S., Schermuly, R. T., Wilkens, H. and Hoeper, M. M. (2015). Riociguat: Stimulator of Soluble Guanylate-cyclase. Pneumologie, 69 (3). S. 135 - 144. STUTTGART: GEORG THIEME VERLAG KG. ISSN 1438-8790

Leuenhagen, S., Burghaus, L., Kukolja, J., Rosenkranz, S., Kabbasch, C., Fink, G. R. and Onur, O. A. (2016). The Therapeutic Dilemma in Treatment of Intracranial Infectious Aneurysm in Patients with Infective Endocarditis: Proposal for a Patient-Centered, Interdisciplinary Treatment Concept. Forschritte Neurol. Psychiatr., 84 (7). S. 411 - 419. STUTTGART: GEORG THIEME VERLAG KG. ISSN 1439-3522

Markl, A., Blank, N., Krysztofiak, K., Berghausen, E., Vantler, M. and Rosenkranz, S. (2015). Insulin receptor substrate 2 (IRS2) overexpression in vascular smooth muscle cells (VSMC) blunts neointima formation in mice. Eur. Heart J., 36. S. 1025 - 1026. OXFORD: OXFORD UNIV PRESS. ISSN 1522-9645

Mauri, V., Reimann, A., Stern, D., Madershahian, N., Scherner, M., Kuhn, E., Rosenkranz, S., Baldus, S., Rudolph, V. and Rudolph, T. K. (2016). Postprocedural pacemaker rate is related to implantation depth and calcium distribution pattern after Sapien 3 implantation. Eur. Heart J., 37. S. 146 - 147. OXFORD: OXFORD UNIV PRESS. ISSN 1522-9645

Noordegraaf, A. Vonk, Channick, R., Cottreel, E., Kiely, D., Martin, N., Moiseeva, O., Peacock, A., Tawakol, A., Torbicki, A., Rosenkranz, S. and Galie, N. (2020). Results from the REPAIR Study Final Analysis: Effects of Macitentan on Right Ventricular (RV) Remodelling in Pulmonary Arterial Hypertension (PAH). J. Heart Lung Transplant., 39 (4). S. S16 - 2. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1557-3117

Opitz, C. F., Blindt, R., Blumberg, F., Borst, M. M., Bruch, L., Leuchte, H., Nagel, C., Peters, K., Rosenkranz, S., Schranz, D., Skowasch, D., Lichtblau, M., Tiede, H., Weil, J. and Ewert, R. (2010). Pulmonary hypertension: hemodynamic evaluation - Recommendations of the Cologne Consensus Conference 2010. Dtsch. Med. Wochenschr., 135. S. S78 - 9. STUTTGART: GEORG THIEME VERLAG KG. ISSN 1439-4413

Opitz, C. F., Hoeper, M. M., Huscher, D., Pittrow, D. and Rosenkranz, S. (2015). Treating pulmonary hypertension in patients with heart failure and preserved ejection fraction: safety and efficacy in comparison to IPAH in COMPERA. Eur. Heart J., 36. S. 382 - 383. OXFORD: OXFORD UNIV PRESS. ISSN 1522-9645

Preston, I., Frantz, R., Hemnes, A., Rosenkranz, S., Skaara, H., Pfister, T., Humbert, M. and Howard, L. S. (2018). Rationale and Design of TRACE: A Double-Blind, Placebo-Controlled Phase 4 Study in Pulmonary Arterial Hypertension to Assess the Effect of Selexipag on Physical Activity, Patient-Reported Symptoms and Their Impact, in Daily Life. Am. J. Respir. Crit. Care Med., 197. NEW YORK: AMER THORACIC SOC. ISSN 1535-4970

Rosenkranz, S. (2017). Cava-Filter not used in Anticoagulation. Kardiologe, 11 (4). S. 248 - 249. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1864-9726

Rosenkranz, S. (2014). Cor pulmonale and pulmonary hypertension. Update after the world conference in Nice. Herz, 39 (1). S. 58 - 66. MUNICH: URBAN & VOGEL. ISSN 1615-6692

Rosenkranz, S. (2017). Extended Anticoagulation after Pulmonary Embolism. Kardiologe, 11 (1). S. 2 - 3. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1864-9726

Rosenkranz, S. (2020). Pulmonary Hypertension in Left Heart Disease. Kardiologe, 14 (1). S. 2 - 3. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1864-9726

Rosenkranz, S. (2017). Temporary Cava-Filter. Kardiologe, 11 (1). S. 2 - 3. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1864-9726

Rosenkranz, S. (2017). Updated Nice-Classification of pulmonary Hypertension. Kardiologe, 11 (1). S. 3 - 4. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1864-9726

Rosenkranz, S. (2017). Venous Thromboembolism: Screening for malignant Diseases? Kardiologe, 11 (1). S. 3 - 4. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1864-9726

Rosenkranz, S. (2014). We heal wounds. Dtsch. Med. Wochenschr., 139 (33). S. 1645 - 1647. STUTTGART: GEORG THIEME VERLAG KG. ISSN 1439-4413

Rosenkranz, S., Baldus, S., Grunig, E., Klose, H., Opitz, C. and Hoeper, M. M. (2016). Comment on the 2015 ESC/ERS guidelines on the diagnosis and treatment of pulmonary hypertension. Kardiologe, 10 (4). S. 211 - 222. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1864-9726

Rosenkranz, S., Behr, J., Ewert, R., Ghofrani, H. A., Gruenig, E., Halank, M., Hoeper, M. M., Leuchte, H. H., Olschewski, H., Schmeisser, A., Speich, R., Wilkens, H. and Opitz, C. F. (2011). Right heart catheterization in pulmonary hypertension. Dtsch. Med. Wochenschr., 136 (50). S. 2601 - 2617. STUTTGART: GEORG THIEME VERLAG KG. ISSN 1439-4413

Rosenkranz, S., Bonderman, D., Buerke, M., Felgendreher, R., ten Freyhaus, H., Gruenig, E., de Haan, F., Hammerstingl, C., Harreuter, A., Hohenforst-Schmidt, W., Kindermann, I., Kindermann, M., Kleber, F. -X., Kuckeland, M., Kuebler, W. M., Mertens, D., Mitrovic, V., Opitz, C., Schmeisser, A., Schulz, U., Speich, R., Zeh, W. and Weil, J. (2010). Pulmonary hypertension due to left heart disease: Recommendations of the Cologne Consensus Conference 2010. Dtsch. Med. Wochenschr., 135. S. S102 - 13. STUTTGART: GEORG THIEME VERLAG KG. ISSN 1439-4413

Rosenkranz, S., Channick, R., Chin, K., Jenner, B., Gaine, S., Galie, N., Ghofrani, H. A., Hoeper, M. M., McLaughlin, V, Preiss, R., Rubin, L., Simonneau, G., Sitbon, O., Tapson, V and Lang, I (2020). Efficacy and safety of selexipag in pulmonary arterial hypertension (PAH) patients with and without significant cardiovascular (CV) comorbidities. Pneumologie, 74. S. S62 - 2. STUTTGART: GEORG THIEME VERLAG KG. ISSN 1438-8790

Rosenkranz, S., Ghofrani, H. A., Gruenig, E. and Hoeper, M. M. (2010). Cologne consenus conference on pulmonary hypertension 2010. Dtsch. Med. Wochenschr., 135. S. S64 - 3. STUTTGART: GEORG THIEME VERLAG KG. ISSN 1439-4413

Rosenkranz, S., Ghofrani, H. A., Gruenig, E., Klose, H., Olschewski, H. and Hoeper, M. M. (2016). Cologne Consensus Conference on Pulmonary Hypertension 2016. Dtsch. Med. Wochenschr., 141. S. S1 - 4. STUTTGART: GEORG THIEME VERLAG KG. ISSN 1439-4413

Rosenkranz, S., Kramer, T., Gerhardt, F., Opitz, C., Olsson, K. M. and Hoeper, M. M. (2019). Pulmonary hypertension in HFpEF and HFrEF: Pathophysiology, diagnosis, treatment approaches. Herz, 44 (6). S. 483 - 491. MUNICH: URBAN & VOGEL. ISSN 1615-6692

Rosenkranz, S., Lang, I. M., Blindt, R., Bonderman, D., Bruch, L., Diller, G. P., Felgendreher, R., Gerges, C., Hohenforst-Schmidt, W., Holt, S., Jung, C., Kindermann, I., Kramer, T., Kuebler, W. M., Mitrovic, V., Riedel, A., Rieth, A., Schmeisser, A., Wachter, R., Weil, J. and Opitz, C. (2016). Pulmonary hypertension associated with left heart disease: recommendations of the Cologne Consensus Conference 2016. Dtsch. Med. Wochenschr., 141. S. S48 - 12. STUTTGART: GEORG THIEME VERLAG KG. ISSN 1439-4413

Sulica, R., Frey, R., Van Der Mey, D., Platt, D. M., Saleh, S., Steiper, M. and Rosenkranz, S. (2017). The Rationale For A Washout Period When Switching Patients From Pde5i To Riociguat. Am. J. Respir. Crit. Care Med., 195. NEW YORK: AMER THORACIC SOC. ISSN 1535-4970

Ten Freyhaus, H., Batool, M., Berghausen, E. M., Joseph, C., Zierden, M., Vantler, M., Baldus, S. and Rosenkranz, S. (2017). The six-transmembrane protein Stamp2 protects from pulmonary vascular remodeling and pulmonary hypertension in mice. Eur. Heart J., 38. S. 1340 - 1341. OXFORD: OXFORD UNIV PRESS. ISSN 1522-9645

Ten Freyhaus, H., Batool, M., Berghausen, E. M., Zierden, M., Vantler, M., Baldus, S. and Rosenkranz, S. (2016). The six-transmembrane protein Stamp2 protects from experimental pulmonary hypertension. Eur. Heart J., 37. S. 908 - 909. OXFORD: OXFORD UNIV PRESS. ISSN 1522-9645

Ten Freyhaus, H., Berghausen, E. M., Janssen, W., Leuchs, M., Zierden, M., Vantler, M., Baldus, S., Schermuly, R. T., Tallquist, M. D. and Rosenkranz, S. (2014). Critical role of PDGF-induced PI3 kinase and PLCg signaling in human and experimental pulmonary hypertension. Eur. Heart J., 35. S. 198 - 199. OXFORD: OXFORD UNIV PRESS. ISSN 1522-9645

Ten Freyhaus, H., Dumitrescu, D., Schnorbach, S., Kappert, K., Viethen, T., Hellmich, M., Baldus, S., Hunuzelmann, N. and Rosenkranz, S. (2015). CT-proET1 predicts survival in scleroderma-associated pulmonary hypertension. Eur. Heart J., 36. S. 627 - 628. OXFORD: OXFORD UNIV PRESS. ISSN 1522-9645

Ten Freyhaus, H., Mollenhauer, M., Bokredenghel, S., Bablok, S., Ruther, T., Proksch, C., Berghausen, E. M., Vantler, M., Rosenkranz, S., Baldus, S. and Rudolph, V. (2017). Deficiency of the six-transmembrane protein Stamp2 promotes structural remodeling and systolic dysfunction in left ventricular myocardial ischemia-reperfusion injury. Eur. Heart J., 38. S. 1138 - 1139. OXFORD: OXFORD UNIV PRESS. ISSN 1522-9645

Tichelbaecker, T., Dumitrescu, D., Gerhardt, F., Stern, D., Wissmueller, M., Adam, M., Schmidt, T., Frerker, C., Pfister, R., Halbach, M., Baldus, S. and Rosenkranz, S. (2019). Pulmonary hypertension and valvular heart disease. Herz, 44 (6). S. 491 - 502. MUNICH: URBAN & VOGEL. ISSN 1615-6692

Vantler, M., Alfitian, J., Gerhardt, M., Berghausen, E. M., Zierden, M., Baldus, S., Sandner, P. and Rosenkranz, S. (2018). SGC-stimulation via BAY 41-2272 exerts antiatherogenic effects in LDLR- and ApoE-deficient mice. Eur. Heart J., 39. S. 803 - 804. OXFORD: OXFORD UNIV PRESS. ISSN 1522-9645

Vantler, M., Jesus, J., Leppaenen, O., Chen, X., Gerhardt, M., Berghausen, E., Zierden, M., Baldus, S., Zhao, J. J. and Rosenkranz, S. (2015). PI3Kalpha induced SMC migration and cell cycle progression is crucial for neointima formation following vascular injury. Eur. Heart J., 36. S. 375 - 376. OXFORD: OXFORD UNIV PRESS. ISSN 1522-9645

Zierden, M., Millarg, C., Berghausen, E. M., Baldus, S., Vantler, M. and Rosenkranz, S. (2018). PI3-kinase delta protects against atherosclerosis progression by controlling regulatory T-cell homeostasis and function. Eur. Heart J., 39. S. 254 - 255. OXFORD: OXFORD UNIV PRESS. ISSN 1522-9645

Zierden, M., Millarg, C., Herbers, C., Vantler, M., Berghausen, E., Baldus, S. and Rosenkranz, S. (2014). Hematopoietic PI3-kinase delta-deficiency aggravates lesional macrophage infiltration and atherosclerosis in LDLR-/- mice. Eur. Heart J., 35. S. 614 - 615. OXFORD: OXFORD UNIV PRESS. ISSN 1522-9645

Zierden, M., Millarg, C., Vantler, M., Berghausen, E. M., Baldus, S. and Rosenkranz, S. (2017). Hematopoietic PI3-kinase delta-deficiency aggravates atherosclerosis by impairment of regulatory T cells. Eur. Heart J., 38. S. 1071 - 1072. OXFORD: OXFORD UNIV PRESS. ISSN 1522-9645

Zierden, M., Millarg, C., Vantler, M., Berghausen, E. M., Baldus, S. and Rosenkranz, S. (2016). Hematopoietic PI3-kinase delta-deficiency causes B-1 cell depletion, impaired regulatory T-cell function and aggravated atherosclerosis in LDLR-/- mice. Eur. Heart J., 37. S. 1008 - 1010. OXFORD: OXFORD UNIV PRESS. ISSN 1522-9645

ten Freyhaus, H., Vogel, D., Lehmann, C., Kuemmerle, T., Wyen, C., Faetkenheuer, G. and Rosenkranz, S. (2014). Echocardiographic screening for pulmonary arterial hypertension in HIV-positive patients. Infection, 42 (4). S. 737 - 742. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1439-0973

This list was generated on Thu Oct 21 04:39:29 2021 CEST.